X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (84) 84
oncology (84) 84
index medicus (66) 66
male (55) 55
female (54) 54
middle aged (49) 49
colorectal cancer (47) 47
aged (45) 45
cancer (45) 45
adult (38) 38
colorectal neoplasms - drug therapy (38) 38
antineoplastic agents - therapeutic use (28) 28
colorectal neoplasms - pathology (28) 28
article (27) 27
metastasis (26) 26
pharmacology & pharmacy (26) 26
research (26) 26
colorectal neoplasms - genetics (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (24) 24
care and treatment (24) 24
medicine & public health (24) 24
prognosis (24) 24
aged, 80 and over (23) 23
chemotherapy (23) 23
drug therapy (20) 20
patients (20) 20
bevacizumab (19) 19
metastases (19) 19
neoplasm metastasis (19) 19
clinical trials (17) 17
disease-free survival (17) 17
genetic aspects (17) 17
treatment outcome (17) 17
cetuximab (16) 16
colorectal carcinoma (16) 16
fluorouracil (16) 16
oxaliplatin (15) 15
pharmacology/toxicology (15) 15
survival (15) 15
breast-cancer (14) 14
fluorouracil - administration & dosage (13) 13
tumors (13) 13
1st-line treatment (12) 12
biomarkers, tumor - genetics (12) 12
camptothecin - analogs & derivatives (12) 12
cells (12) 12
expression (12) 12
irinotecan (12) 12
leucovorin (12) 12
polymorphism, single nucleotide (12) 12
angiogenesis (11) 11
antineoplastic agents - adverse effects (11) 11
colorectal-cancer (11) 11
dose-response relationship, drug (11) 11
metastatic colorectal cancer (11) 11
neoplasms - drug therapy (11) 11
5-fluorouracil (10) 10
animals (10) 10
antineoplastic agents - administration & dosage (10) 10
antineoplastic agents - pharmacology (10) 10
cancer patients (10) 10
deoxyribonucleic acid--dna (10) 10
dosage and administration (10) 10
fluorouracil - therapeutic use (10) 10
medical colleges (10) 10
medical research (10) 10
single nucleotide polymorphisms (10) 10
single-nucleotide polymorphism (10) 10
analysis (9) 9
biomarkers (9) 9
colon (9) 9
colorectal neoplasms - mortality (9) 9
neoplasm staging (9) 9
polymerase chain reaction (9) 9
survival rate (9) 9
therapy (9) 9
antibodies, monoclonal - therapeutic use (8) 8
cancer research (8) 8
colon-cancer (8) 8
genotype (8) 8
health aspects (8) 8
leucovorin - administration & dosage (8) 8
phase-i (8) 8
risk factors (8) 8
solid tumors (8) 8
trial (8) 8
vascular endothelial growth factor (8) 8
antibodies, monoclonal, humanized (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
camptothecin - therapeutic use (7) 7
carcinoma (7) 7
drug administration schedule (7) 7
gastroenterology and hepatology (7) 7
genes (7) 7
growth (7) 7
growth-factor receptor (7) 7
hematology, oncology and palliative medicine (7) 7
maximum tolerated dose (7) 7
medicine, experimental (7) 7
metastatic colorectal-cancer (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Gastroenterology Clinics of North America, ISSN 0889-8553, 03/2012, Volume 41, Issue 1, pp. 189 - 209
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 937 - 948
Summary Background Tumour mutational status is an important determinant of the response of metastatic colorectal cancer to targeted treatments. However, the... 
Hematology, Oncology and Palliative Medicine | KRAS MUTATIONS | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS IRINOTECAN | ONCOLOGY | RANDOMIZED PHASE-III | INHIBITS GROWTH | ACQUIRED-RESISTANCE | FLUOROURACIL | PLACEBO PLUS | TUMOR-GROWTH | Predictive Value of Tests | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Clinical Trials, Phase III as Topic | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Precision Medicine | Receptor, TIE-1 - blood | Phosphatidylinositol 3-Kinases - blood | Genetic Predisposition to Disease | Adenocarcinoma - blood | ras Proteins - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Phenotype | Class I Phosphatidylinositol 3-Kinases | Biomarkers, Tumor - genetics | ras Proteins - genetics | Patient Selection | DNA, Neoplasm - blood | Female | Adenocarcinoma - genetics | Retrospective Studies | Pyridines - therapeutic use | Colorectal Neoplasms - mortality | Colorectal Neoplasms - blood | Kaplan-Meier Estimate | Proportional Hazards Models | Phenylurea Compounds - therapeutic use | Proto-Oncogene Proteins B-raf - blood | Proto-Oncogene Proteins - genetics | Treatment Outcome | Randomized Controlled Trials as Topic | Biomarkers, Tumor - blood | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Proto-Oncogene Proteins B-raf - genetics | Aged | DNA, Neoplasm - genetics | Colorectal Neoplasms - pathology | Proto-Oncogene Proteins - blood | Adenocarcinoma - mortality | Medical colleges | Medical research | Cancer patients | Prognosis | Liver | DNA | Colorectal cancer | Genetic research | Medicine, Experimental | Metastasis
Journal Article